Discover Great Companies Discover Great Clients
Popularity  4893 Claim this company
Wuxi Xinwu District Jiangsu Antibodies Zhi Agents Production Pharmaceutical Sheng Ming Ke Xue Biological Products Healthcare Technology Sheng Wu Ke Ji / Biotechnology Engineering Innovative Drugs Products Wu Chemical Technology Yuan Yan Yao Wei Balls Materials Fen Zi Sheng Wu Xue 科技型中小企业
More

Company Overview

  • Nature: Private Enterprise Size: 100-499 employees Founded: 6年
  • Industry: Pharmaceutical/Bioengineering
  • Full name: Jiangsu Jiye Biopharmaceutical Co., Ltd.。

Development Stage

  • Honors: 科技型中小企业 According to algorithm

About the Company

Jemincare Group, founded in 1999, is a comprehensive large health industry group with more than 12,000 employees. Headquartered in Nanchang, Jiangxi, it has established industrial platforms and R&D institutions in Jiangxi, Beijing, Shanghai, Jiangsu, Zhejiang and other places. In 2019, the group's operating revenue exceeded 35.8 billion yuan, and it was selected into the Xinhua News Agency National Brand Project, ranking among the top ten of China's top 100 pharmaceutical industry for many consecutive years.
Wuxi Jiyu Shanhe Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Jiangxi Jemincare Group. The company is located at No. 12 Changjiang South Road, Xinwu District, Wuxi City, Jiangsu Province. Adhering to the working philosophy of "cherish life, produce with heart" and relying on advanced technology and talent teams, the company currently has 15 dosage forms including large and small volume injections, eye drops, nasal drops, pills, and tablets, 206 drug production approvals, and 55 patents. Product quality and efficacy enjoy widespread quality reputation and market recognition among similar domestic products.
To meet market demand and the needs of new product R&D and implementation, the group plans to build Shanhe Pharmaceutical into a production platform for small-volume injections and high-end formulations. Under the leadership of the group, Shanhe Pharmaceutical will continue to develop and innovate, striving to become a modern pharmaceutical enterprise that is "first-class in China and internationally aligned".
High-end formulation project under construction: the total investment in the new drug project is approximately 1 billion yuan. The project will undertake high-end formulation projects from the Shanghai Research Institute in core key medical fields. It mainly includes: liposomal injections, inhaled nasal sprays, inhaled nebulized liquids, microsphere long-acting formulations, etc. These products are all high-tech-difficulty and high-value-added products.
Innovative drugs & macromolecular biologics production base project under construction: approved in Wuxi in September 2020, covering an area of 67 mu, with a total investment of approximately 1 billion yuan. The project will build a research center, innovative drug production workshops, administrative office areas, intelligent warehousing, power centers, sewage treatment facilities and other auxiliary facilities. The project is scheduled to be completed and put into operation in 2023, and will mainly be used for the production of innovative drugs for COVID-19 neutralizing antibodies and macromolecular innovative drugs, and will also help more *new biomedical achievements benefit patients in the future.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 10,000万(元)
Legal Representative: 徐建
Date Established:
Credit Code: 91320214MA22GGJJXA
Registered Address: 无锡市新吴区锡锦路28号

People who follow this company also follow

Competitors (Similar Companies)

动物保健 兽药/兽用药品 兽药生产 动物健康
农药中间体 化肥/农药 氨基酸 医药中间体
“An in vitro diagnostics enterprise with fully automated chemiluminesce”
制药/药业 医药 医药中间体 兽药/兽用药品
新材料 电子新材料 化学品 化工/化学
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
加工 管道配件 不锈钢制品
新药研发 抗肿瘤药 肿瘤药物 抗癌药物
“Semiconductor equipment manufacturer”
“抗体偶联药物(ADC)等生物偶联药端到端服务”
“Benefiting the people, earning trust worldwide”
生物科技/生物工程 生物制药 基因工程 药物研发

Discover Great Companies, Discover Great Clients

无锡公司名录 无锡“Xinwu District”公司名录 无锡“生物医药”公司名录 无锡“生物制药”公司名录 无锡“医药工业”公司名录 无锡“创新药”公司名录 无锡“大健康”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates